18/06/2019 - 15:02

Bard1 raises $7.5m, makes board changes

18/06/2019 - 15:02

Bookmark

Save articles for future reference.

Cancer-focused medical technology company BARD1 Life Sciences has raised around $7.5 million via a share placement and rights issue, and has appointed two non-executive directors to its board.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options